193 related articles for article (PubMed ID: 19858775)
1. Effects of rho-kinase inhibition on pulmonary hypertension, lung growth, and structure in neonatal rats chronically exposed to hypoxia.
Ziino AJ; Ivanovska J; Belcastro R; Kantores C; Xu EZ; Lau M; McNamara PJ; Tanswell AK; Jankov RP
Pediatr Res; 2010 Feb; 67(2):177-82. PubMed ID: 19858775
[TBL] [Abstract][Full Text] [Related]
2. Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Xu EZ; Kantores C; Ivanovska J; Engelberts D; Kavanagh BP; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1854-64. PubMed ID: 20889845
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
4. Rho-kinase inhibitor prevents bleomycin-induced injury in neonatal rats independent of effects on lung inflammation.
Lee AH; Dhaliwal R; Kantores C; Ivanovska J; Gosal K; McNamara PJ; Letarte M; Jankov RP
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):61-73. PubMed ID: 23947621
[TBL] [Abstract][Full Text] [Related]
5. Rho-kinase inhibitor Y-27632 attenuates pulmonary hypertension in hyperoxia-exposed newborn rats.
Chou HC; Huang LT; Yeh TF; Chen CM
Acta Pharmacol Sin; 2013 Oct; 34(10):1310-6. PubMed ID: 23974518
[TBL] [Abstract][Full Text] [Related]
6. Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide.
McNamara PJ; Murthy P; Kantores C; Teixeira L; Engelberts D; van Vliet T; Kavanagh BP; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2008 Feb; 294(2):L205-13. PubMed ID: 18032699
[TBL] [Abstract][Full Text] [Related]
7. Role of Src tyrosine kinases in experimental pulmonary hypertension.
Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
[TBL] [Abstract][Full Text] [Related]
8. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells.
Garat CV; Crossno JT; Sullivan TM; Reusch JE; Klemm DJ
J Cardiovasc Pharmacol; 2013 Dec; 62(6):539-48. PubMed ID: 24084215
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin prevents and reverses chronic pulmonary hypertension in newborn rats via pleiotropic inhibition of RhoA signaling.
Wong MJ; Kantores C; Ivanovska J; Jain A; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L985-L999. PubMed ID: 27694473
[TBL] [Abstract][Full Text] [Related]
11. Sustained therapeutic hypercapnia attenuates pulmonary arterial Rho-kinase activity and ameliorates chronic hypoxic pulmonary hypertension in juvenile rats.
Peng G; Ivanovska J; Kantores C; Van Vliet T; Engelberts D; Kavanagh BP; Enomoto M; Belik J; Jain A; McNamara PJ; Jankov RP
Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2599-611. PubMed ID: 22505643
[TBL] [Abstract][Full Text] [Related]
12. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, attenuates hyperoxia-induced pulmonary fibrosis in neonatal rats.
Qi XJ; Ning W; Xu F; Dang HX; Fang F; Li J
Int J Clin Exp Pathol; 2015; 8(10):12140-50. PubMed ID: 26722398
[TBL] [Abstract][Full Text] [Related]
13. Role of Rho kinase and Na+/H+ exchange in hypoxia-induced pulmonary arterial smooth muscle cell proliferation and migration.
Walker J; Undem C; Yun X; Lade J; Jiang H; Shimoda LA
Physiol Rep; 2016 Mar; 4(6):. PubMed ID: 27009277
[TBL] [Abstract][Full Text] [Related]
14. Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.
Pankey EA; Thammasiboon S; Lasker GF; Baber S; Lasky JA; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2013 Nov; 305(9):H1288-96. PubMed ID: 23997103
[TBL] [Abstract][Full Text] [Related]
15. Concurrent rho-kinase and tyrosine kinase platelet-derived growth factor inhibition in experimental pulmonary hypertension.
Jasińska-Stroschein M; Owczarek J; Plichta P; Orszulak-Michalak D
Pharmacology; 2014; 93(3-4):145-50. PubMed ID: 24662671
[TBL] [Abstract][Full Text] [Related]
16. A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling.
Jankov RP; Kantores C; Belcastro R; Yi S; Ridsdale RA; Post M; Tanswell AK
Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1162-70. PubMed ID: 15722379
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rho kinase attenuates high flow induced pulmonary hypertension in rats.
Li FH; Xia W; Li AW; Zhao CF; Sun RP
Chin Med J (Engl); 2007 Jan; 120(1):22-9. PubMed ID: 17254483
[TBL] [Abstract][Full Text] [Related]
18. A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.
Jiang BH; Maruyama J; Yokochi A; Mitani Y; Maruyama K
Lung; 2007; 185(5):303-308. PubMed ID: 17721804
[TBL] [Abstract][Full Text] [Related]
19. Endothelin-1-Rho kinase interactions impair lung structure and cause pulmonary hypertension after bleomycin exposure in neonatal rat pups.
Gien J; Tseng N; Seedorf G; Kuhn K; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1090-L1100. PubMed ID: 27760762
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
